Corvalol Phyto 1.16mg + 28mg + 16.4mg tab. # 50

The tablets are white, round, biconvex.

Combined drug, the action of which is due to the properties of its constituent substances.

It has a sedative and antispasmodic effect, a moderate cardiotonic effect (slows down the rhythm and increases the strength of heart contractions), has moderate hypotensive properties.

Ethyl bromisovalerianate has a sedative and antispasmodic effect due to irritation, mainly of receptors in the oral cavity and nasopharynx, a decrease in reflex excitability in the central parts of the nervous system and an increase in inhibition in neurons of the cortex and subcortical structures of the brain, as well as a decrease in the activity of the central vasomotor centers and a direct local effect on spasmolytic activity smooth muscles.

By the nature of the action, it is close to valerian preparations.

Motherwort herb has a pronounced sedative effect, reduces the frequency and increases the strength of heart contractions, exhibits hypotensive properties.

Peppermint oil has a reflex vasodilating, antispasmodic, mild choleretic, antiseptic effect.

The mechanism of action is associated with the ability to irritate the cold" receptors of the oral mucosa and reflexively expand the vessels of the heart and brain.

Eliminates the phenomenon of flatulence due to irritation of the receptors of the mucous membrane of the gastrointestinal tract (GIT), increasing intestinal peristalsis.

Pharmacokinetics:

There are no data on the pharmacokinetics of ethyl bromisovalerianate, motherwort herb and peppermint components.

Indications

As a symptomatic (sedative and vasodilator) agent for functional disorders of the cardiovascular system

neurosis-like states, accompanied by increased irritability, in violation of falling asleep, tachycardia, a state of excitement with pronounced vegetative manifestations

as an antispasmodic agent - for intestinal spasms.

Contraindications

- Hypersensitivity to drug components

- severe renal and / or liver dysfunction

- pregnancy

- lactation period (breastfeeding)

- children under 18 years of age (efficacy and safety have not been established)

- lactose intolerance, lactase deficiency, glucose-galactose malabsorption.

If you have one of the listed diseases / conditions, be sure to consult your doctor before taking the drug.

Carefully:

Dysfunction of the kidneys and / or liver.

Application during pregnancy and lactation

The safety of using the drug Corvalol Fito, tablets during pregnancy has not been established, the use of the drug during pregnancy is contraindicated.

There is no data on the penetration of the components of the drug into breast milk, therefore, if it is necessary to use the drug during lactation, the question of stopping breastfeeding should be decided.

special instructions

There is no experience of using the drug in children under 18 years of age, during pregnancy and during breastfeeding.

Long-term use of the drug in high doses is not recommended, due to the possible toxic effect during the accumulation of bromine in the body.

You should not drink alcohol while using the drug.

Impact on the ability to drive vehicles.

Wed

and fur .:

Due to the possibility of dizziness, decreased concentration of attention and other side effects associated with taking the drug, during the period of treatment, patients are advised to refrain from driving vehicles and engaging in other potentially hazardous activities that require increased concentration of attention, speed of psychomotor and motor reactions.

Side effects

From the immune system: allergic reactions

From the side of the central nervous system: drowsiness, weakness, dizziness, decreased ability to concentrate

FROM

Name ENG

CORVALOL FORTE

Clinical and pharmacological group

A drug with a sedative and antispasmodic effect

ATX code

Other hypnotics and sedatives

Dosage

1.16mg + 28mg + 16.4mg

Structure

Active ingredients: motherwort herb extract (motherwort extract dry) - 14.00 mg or 28.00 mg, ethyl bromisovalerianate (ethyl ester of alpha-bromisovaleric acid) - 8.20 mg or 16.40 mg, peppermint leaf oil (peppermint oil) - 0.58 mg or 1.16 mg.

Excipients: lactose (lactose monohydrate) - 79.21 mg or 158.42 mg, betadex (beta-cyclodextrin) - 55.55 mg or 111.10 mg, potato starch - 35.56 mg or 71.12 mg, magnesium alumometasilicate (Neusilin UFL 2) - 4.00 mg or 8.00 mg, talc - 2.00 mg or 4.00 mg, magnesium stearate - 0.90 mg or 1.80 mg.

Indications

As a symptomatic (sedative and vasodilator) agent for functional disorders of the cardiovascular system

neurosis-like states, accompanied by increased irritability, in violation of falling asleep, tachycardia, a state of excitement with pronounced vegetative manifestations

as an antispasmodic agent - for intestinal spasms.

INN / Active ingredient

motherwort herb extract (motherwort extract dry), ethyl bromisovalerianate (ethyl ester of alpha-bromisovaleric acid), peppermint leaf oil (peppermint oil)

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 2 years

Contraindications

Hypersensitivity to drug components

- severe renal and / or liver dysfunction

- pregnancy

- lactation period (breastfeeding)

- children under 18 years of age (efficacy and safety have not been established)

lactose intolerance, lactase deficiency, glucose-galactose malabsorption.

If you have one of the listed diseases / conditions, be sure to consult your doctor before taking the drug.

Carefully:

Dysfunction of the kidneys and / or liver.

Specifications

Category

Sedatives

,

Antipsychotics

,

Neurological disorders

Scope of the drug

Neurology, psychiatry

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

fifty

Scope of application

Cardiology

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Pharmstandard

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Sedative

Anatomical and therapeutic characteristics

N05CM Other hypnotics and sedatives

Dosage form

Pills

Expiration date in days

730

Package weight, g

45

Mode of application

:

For oral administration, before meals, with water.

For tablets, 0.58 mg + 14.00 mg + 8.20 mg: for adults, 2 tablets 2 times a day.

For tablets, 1.16 mg + 28.00 mg + 16.40 mg: for adults, 1 tablet 2 times a day.

With tachycardia, a single dose may be increased to 3 tablets.

The maximum daily dose is 6 tablets.

The course of treatment is 4 weeks (28 days).

The duration of admission can be increased on the recommendation of a doctor.

Dosage (volume) of the substance in the preparation

:

Per tablet: motherwort herb extract (motherwort extract dry) - 14.00 mg or 28.00 mg, ethyl bromisovalerianate (ethyl ester of alpha-bromisovaleric acid) - 8.20 mg or 16.40 mg, peppermint leaf oil (peppermint oil) - 0.58 mg

Information on technical characteristics, delivery set, country of manufacture "